The US healthcare market is valued at $2.8 trillion, with diagnostic testing directing 70% of all spend (1, 2). To put that into perspective, 13% of US gross domestic product (GDP), or 13 cents of every dollar, is guided by what occurs at the tip of a needle, urine cup, or specimen vial. FactorOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.